Revenue Cycle

Defining 'integral' tricky for self-administered drugs

Briefings on APCs, February 1, 2012

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on APCs.

Self-administered drugs present a significant issue for coders, especially when considering how they may or may not be covered by Medicare Part B. In many instances, payers may consider a drug to be self-administered in some circumstances but not in others. As a result, coders must pay special attention to how these drugs are used within their setting.

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on APCs.

Most Popular